BUM

Company Overview

Snapshot

Founded in February 2020 by Abraham Shoshani, BUM operates with 1–10 employees. The company is currently in the Pre-Funding stage, focusing on the development of its patented orthopedic treatment device. Its technology has received approval from Prof. Meir Libergal, Head of the orthopedic branch at Hadassah hospital conglomerate.

Business overview

BUM is a medical device company specializing in orthopedic treatment for back and knee pain, offering non-surgical approaches. The company's core technology combines mechanics, electronics, pneumatics, and software to create a device with two pedals that react differentially to foot pressure, aiming to radically change patient posture to be more erect, thereby reducing pressure on the backbone vertebrae and knees. BUM serves the healthcare and life sciences sectors, specifically targeting the medical devices industry with its innovative medical products.

Company Intelligence Q&A

What is BUM's primary focus?

BUM is focused on developing a new orthopedic treatment for back and knee pain using a medical device that aims to provide non-surgical solutions.

Who founded BUM?

BUM was founded by Abraham Shoshani, who serves as the Director of Scientific Research and Development.

When was BUM founded?

BUM was founded in February 2020.

What is the current employee count at BUM?

BUM currently has 1–10 employees.

Has BUM's technology received any endorsements?

Yes, BUM's technology has been approved by Prof. Meir Libergal, who is the Head of the orthopedic branch across the Hadassah hospital conglomerate.